Skip to main content

Table 6 Comparison of patients with drug-resistant epilepsy and with 1-year remission at the end of the study by etiology of symptomatic epilepsy

From: The long-term prognosis and predictors of epilepsy: a retrospective study in 820 patients

 

DRE (%) n = 160

Remission (%) n = 100

OR (95% CI)

P-value

Cerebral trauma

38 (23.8)

28 (28.0)

0.80 (0.45–1.41)

0.444

Mesial temporal sclerosis

38 (23.8)

18 (18.0)

1.42 (0.76– 2.66)

0.273

Meningitis/encephalitis

33 (20.6)

8 (8.0)

2.99 (1.32–6.77)

0.007

Unclear encephalomalacia

11 (6.9)

11 (11.0)

0.60 (0.25–1.43)

0.245

Cortical malformation

11 (6.9)

6 (6.0)

1.16 (0.41–3.23)

0.781

Perinatal brain injury

5 (3.1)

8 (8.0)

0.37 (0.12–1.17)

0.079

Cerebral vascular malformations

4 (2.5)

2 (2.0)

1.67 (0.30–9.23)

0.693

Neurocutaneous syndromes

2 (1.3)

0 (0)

NC

0.262

Cerebral tumor

1 (0.6)

1 (1.0)

0.62 (0.04–10.07)

1.000

Stroke

0

2 (2.0)

NC

0.14

Unknown

17 (10.6)

16 (16.0)

0.70 (0.34–1.45)

0.334

  1. DRE drug resistant epilepsy, NC not calculated because one of the cells has a zero value, 95% CI 95% confidence intervals